APA (7th ed.) Citation

Gbyli, R., Song, Y., Liu, W., Gao, Y., Chandhok, N. S., Fu, X., . . . Halene, S. (2019). PARP Inhibitors Are Effective in IDH1/2 Mutant MDS and AML Resistant to Targeted IDH Inhibitors. Blood, 134(Supplement_1), 4222. https://doi.org/10.1182/blood-2019-130814

Chicago Style (17th ed.) Citation

Gbyli, Rana, et al. "PARP Inhibitors Are Effective in IDH1/2 Mutant MDS and AML Resistant to Targeted IDH Inhibitors." Blood 134, no. Supplement_1 (2019): 4222. https://doi.org/10.1182/blood-2019-130814.

MLA (9th ed.) Citation

Gbyli, Rana, et al. "PARP Inhibitors Are Effective in IDH1/2 Mutant MDS and AML Resistant to Targeted IDH Inhibitors." Blood, vol. 134, no. Supplement_1, 2019, p. 4222, https://doi.org/10.1182/blood-2019-130814.